Oxycodone and Microangiopathic haemolytic anaemia - a phase IV clinical study of FDA data

Summary:

Microangiopathic haemolytic anaemia is reported as a side effect among people who take Oxycodone (oxycodone hydrochloride), especially for people who are male, 40-49 old, also take Heparin, and have Deep venous thrombosis.

The phase IV clinical study analyzes which people have Microangiopathic haemolytic anaemia when taking Oxycodone. It is created by eHealthMe based on reports of 159,853 people who have side effects when taking Oxycodone from the FDA, and is updated regularly.

What is Oxycodone?

Oxycodone has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 162,592 Oxycodone users. Check the latest studies of Oxycodone.

What is Microangiopathic haemolytic anaemia?

Microangiopathic haemolytic anaemia (anaemia due to inability of bone marrow to compensate the premature destruction of red blood cells) is found to be associated with 99 drugs and 233 conditions by eHealthMe. Check the latest studies of Microangiopathic haemolytic anaemia.

On Jul, 15, 2026

159,853 people reported to have side effects when taking Oxycodone.
Among them, 12 people (0.01%) have Microangiopathic haemolytic anaemia.

Could Oxycodone cause Microangiopathic haemolytic anaemia?

Among these 12 people:

What is the gender of people who have Microangiopathic haemolytic anaemia when taking Oxycodone? *

female: 16.67 %
male: 83.33 %

What is the age of people who have Microangiopathic haemolytic anaemia when taking Oxycodone? *

What are other drugs people take besides Oxycodone? *

What are other side effects people have besides Microangiopathic haemolytic anaemia? *

Thrombocytopenia (decrease of platelets in blood): 7 people, 58.33%
Thrombotic Microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury): 7 people, 58.33%
Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 2 people, 16.67%
Headache (pain in head): 2 people, 16.67%
Leukocytosis (increased white blood cells): 2 people, 16.67%
Hyperbilirubinaemia (excess of bilirubin in the blood): 2 people, 16.67%
Thrombotic Thrombocytopenic Purpura (a rare blood disorder characterized by clotting in small blood vessels of the body): 1 person, 8.33%
Hemiparesis (weakness on one side of the body): 1 person, 8.33%
Acute Kidney Failure: 1 person, 8.33%
Blood Creatinine Increased: 1 person, 8.33%

What are the existing conditions these people have? *

Type 1 Diabetes: 6 people, 50.00%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 6 people, 50.00%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 6 people, 50.00%
Soft Tissue Infection: 5 people, 41.67%
Lung Cancer - Non-Small Cell (lung cancer): 2 people, 16.67%
Stress And Anxiety: 1 person, 8.33%
Schizoaffective Disorder (a mental disorder characterized by disordered thought): 1 person, 8.33%
High Blood Cholesterol: 1 person, 8.33%
Gastric Cancer (stomach cancer): 1 person, 8.33%
Diabetes: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Oxycodone and have Microangiopathic haemolytic anaemia?

- Check whether Microangiopathic haemolytic anaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Oxycodone:

Oxycodone (162,592 reports)

Browse all side effects of Oxycodone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Microangiopathic haemolytic anaemia:

Microangiopathic haemolytic anaemia (99 drugs)

Browse all the conditions that are associated with Microangiopathic haemolytic anaemia:

Microangiopathic haemolytic anaemia (233 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on oxycodone hydrochloride (the active ingredients of Oxycodone) and Oxycodone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.